Publications dans lesquelles il/elle collabore avec MANUELA IGARTUA OLAECHEA (46)

2011

  1. Novel extended-release formulation of lovastatin by one-step melt granulation: In vitro and in vivo evaluation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 77, Núm. 2, pp. 306-312

2010

  1. In vivo evaluation of two new sustained release formulations elaborated by one-step melt granulation: Level A in vitro-in vivo correlation

    European Journal of Pharmaceutics and Biopharmaceutics, Vol. 75, Núm. 2, pp. 232-237

2007

  1. Proceedings del VIII Congreso de la Sociedad Española de Farmacia Industrial yGalénica

    Leioa : Universidad del País Vasco. Servicio Editorial = Euskal Herriko Unibertsitatea. Argitalpen Zerbitzua, 2007

2005

  1. Preparation of sustained release hydrophilic matrices by melt granulation in a high-shear mixer

    Journal of Pharmacy and Pharmaceutical Sciences, Vol. 8, Núm. 2, pp. 132-140

2003

  1. A glimmer of hope for diabetics?

    Trends in Biotechnology, Vol. 21, Núm. 7, pp. 289-290

  2. Cell microencapsulation technology for biomedical purposes: Novel insights and challenges

    Trends in Pharmacological Sciences, Vol. 24, Núm. 5, pp. 207-210

  3. Controversies over stem cell research

    Trends in Biotechnology, Vol. 21, Núm. 3, pp. 109-112

  4. Desarrollo de comprimidos de liberación sostenida de teofilina obtenidos mediante granulación por fusión

    VI Congreso de la Sociedad Española de Farmacia Industrial y Galénica. 3ª Jornadas de Tecnología Farmecéutica. Granada, 9-11 de febrero de 2003.: Libro de Comunicaciones (Comares), pp. 333-336

  5. Development and optimisation of alginate-PMCG-alginate microcapsules for cell immobilisation

    International Journal of Pharmaceutics, Vol. 259, Núm. 1-2, pp. 57-68

  6. Ehun-ingeniaritza: XXI. mendeko medikuntza

    Elhuyar: zientzia eta teknika, Núm. 190, pp. 14-17

  7. Immune response after oral administration of the encapsulated malaria synthetic peptide SPf66

    International Journal of Pharmaceutics, Vol. 260, Núm. 2, pp. 273-282

  8. Immune responses to orally administered PLGA microparticles: Influence of oil vehicles and surfactive agents

    Journal of Microencapsulation, Vol. 20, Núm. 4, pp. 525-536

  9. Survival of different cell lines in alginate-agarose microcapsules

    European Journal of Pharmaceutical Sciences, Vol. 18, Núm. 1, pp. 23-30

2002

  1. Biocompatibility of microcapsules for cell immobilization elaborated with different type of alginates

    Biomaterials, Vol. 23, Núm. 18, pp. 3825-3831

  2. Encapsulated cell technology: From research to market

    Trends in Biotechnology, Vol. 20, Núm. 9, pp. 382-387

  3. Influence of dose and immunization route on the serum Ig G antibody response to BSA loaded PLGA microspheres

    Vaccine, Vol. 20, Núm. 17-18, pp. 2181-2190

  4. Preparation and stability of agarose microcapsules containing BCG

    Journal of Microencapsulation, Vol. 19, Núm. 2, pp. 237-244

  5. Remarkably high antibody levels and protection against P. falciparum malaria in Aotus monkeys after a single immunisation of SPf66 encapsulated in PLGA microspheres

    Vaccine, Vol. 20, Núm. 13-14, pp. 1707-1710

  6. Size dependent immune response after subcutaneous, oral and intranasal administration of BSA loaded nanospheres

    Vaccine, Vol. 21, Núm. 1-2, pp. 67-77

2001

  1. Biodegradable PLGA microspheres as a delivery system for malaria synthetic peptide SPf66

    Vaccine, Vol. 19, Núm. 31, pp. 4445-4451